Back to normal version
Home > About breast cancer > Treatment > Drug therapy > Chemotherapy

New ways of giving chemotherapy

Researchers at many cancer centres are looking for better ways of giving chemotherapy to women with breast cancer.
Some of these studies are looking for women to take part. Other studies have enough women, and researchers are now watching the effects of the different treatments the women have had.

You can find out more about chemotherapy trials for women with breast cancer in the UK from the National Cancer Research Network or Cancer Research UK.


Studies underway


TACT

TACT is looking to see whether women with breast cancer would benefit from taxane treatment at an earlier stage than it is currently available. The study is comparing two combinations of chemotherapy - both of which contain an anthracycline (FEC or Epi-CMF) - with FEC followed by docetaxel in women with early breast cancer.

DEVA

DEVA is comparing a combination of the anthracycline, epirubicin, and the taxane, docetaxel, with epirubicin on its own in women whose oestrogen receptor test was positive.

Top of page    Print version    Send to a friend